Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmonoatomic cation channel activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80

4.06e-073439011GO:0005261
GeneOntologyMolecularFunctionmonoatomic ion channel activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80

6.82e-064599011GO:0005216
GeneOntologyMolecularFunctionmetal ion transmembrane transporter activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1

7.71e-064659011GO:0046873
GeneOntologyMolecularFunctionchannel activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80

2.38e-055259011GO:0015267
GeneOntologyMolecularFunctionpassive transmembrane transporter activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80

2.43e-055269011GO:0022803
GeneOntologyMolecularFunctioncalcium channel activity

CACNA1C CACNA1E CACNA1F TRPC4AP PKD1 CNGB1

2.58e-05129906GO:0005262
GeneOntologyMolecularFunctionhigh voltage-gated calcium channel activity

CACNA1C CACNA1E CACNA1F

3.11e-0514903GO:0008331
GeneOntologyMolecularFunctionmonoatomic cation transmembrane transporter activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1 UNC80

4.23e-056649012GO:0008324
GeneOntologyMolecularFunctioncalcium ion transmembrane transporter activity

CACNA1C CACNA1E CACNA1F TRPC4AP PKD1 CNGB1

6.25e-05151906GO:0015085
GeneOntologyMolecularFunctionvoltage-gated monoatomic cation channel activity

CACNA1C CACNA1E CACNA1F KCNB1 KCNV2 KCNS1

6.48e-05152906GO:0022843
GeneOntologyMolecularFunctiontransmembrane transporter activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 ABCA6 KCNV2 PKD1 SLC4A10 ABCB11 KCNS1 CNGB1 SLC16A12 UNC80 SLC2A5

6.80e-0511809016GO:0022857
GeneOntologyMolecularFunctionsmall GTPase binding

RANBP1 RANBP2 MYO5B INF2 PLEKHG2 XPO1 GDI2 PLCE1

1.01e-04321908GO:0031267
GeneOntologyMolecularFunctioninorganic cation transmembrane transporter activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1

1.18e-046279011GO:0022890
GeneOntologyMolecularFunctionvoltage-gated monoatomic ion channel activity

CACNA1C CACNA1E CACNA1F KCNB1 KCNV2 KCNS1

1.74e-04182906GO:0005244
GeneOntologyMolecularFunctionvoltage-gated channel activity

CACNA1C CACNA1E CACNA1F KCNB1 KCNV2 KCNS1

1.85e-04184906GO:0022832
GeneOntologyMolecularFunctiontransporter activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 ABCA6 KCNV2 PKD1 SLC4A10 ABCB11 KCNS1 CNGB1 SLC16A12 UNC80 SLC2A5

1.90e-0412899016GO:0005215
GeneOntologyMolecularFunctionGTPase binding

RANBP1 RANBP2 MYO5B INF2 PLEKHG2 XPO1 GDI2 PLCE1

2.21e-04360908GO:0051020
GeneOntologyMolecularFunctionmonoatomic ion transmembrane transporter activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1 UNC80

2.26e-047939012GO:0015075
GeneOntologyMolecularFunctioninorganic molecular entity transmembrane transporter activity

CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 KCNS1 CNGB1

5.95e-047589011GO:0015318
GeneOntologyMolecularFunctiongated channel activity

CACNA1C CACNA1E CACNA1F KCNB1 KCNV2 KCNS1 CNGB1

7.84e-04334907GO:0022836
GeneOntologyMolecularFunctionvoltage-gated calcium channel activity

CACNA1C CACNA1E CACNA1F

1.17e-0346903GO:0005245
GeneOntologyMolecularFunctionGDP-dissociation inhibitor activity

RANBP1 GDI2

2.61e-0317902GO:0005092
GeneOntologyBiologicalProcesscalcium ion transmembrane transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP PKD1 NIPSNAP2 PLCH1 CNGB1 PLCE1

1.10e-063929011GO:0070588
GeneOntologyBiologicalProcesscalcium ion transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A IL16 TRPC4AP PKD1 NIPSNAP2 PLCH1 CNGB1 PLCE1

2.14e-065099012GO:0006816
GeneOntologyBiologicalProcessmonoatomic cation transmembrane transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 UNC80 PLCE1

2.82e-069429016GO:0098655
GeneOntologyBiologicalProcessmetal ion transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A IL16 TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 PLCE1

6.04e-0610009016GO:0030001
GeneOntologyBiologicalProcessmonoatomic cation transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A IL16 TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 UNC80 PLCE1

9.16e-0611579017GO:0006812
GeneOntologyBiologicalProcessinorganic cation transmembrane transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 PLCE1

1.01e-059229015GO:0098662
GeneOntologyBiologicalProcessmonoatomic ion transmembrane transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 UNC80 PLCE1

2.34e-0511159016GO:0034220
GeneOntologyBiologicalProcessinorganic ion transmembrane transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 PLCE1

3.18e-0510179015GO:0098660
GeneOntologyBiologicalProcessorganelle localization

STX19 SCN11A KAT5 KCNB1 MYO5B ATCAY PKD1 ASPM SPO11 ATM XPO1 SDAD1

5.38e-057039012GO:0051640
GeneOntologyBiologicalProcessmonoatomic ion transport

JPH1 CACNA1C CACNA1E CACNA1F SCN11A IL16 TRPC4AP KCNB1 KCNV2 PKD1 SLC4A10 NIPSNAP2 KCNS1 PLCH1 CNGB1 UNC80 PLCE1

8.13e-0513749017GO:0006811
GeneOntologyBiologicalProcessregulation of DNA stability

DDIAS RTF2

1.12e-044902GO:0097752
GeneOntologyBiologicalProcesssignal transduction in response to DNA damage

KAT5 TELO2 HIPK2 ZNF830 CHEK1 ATM

2.44e-04200906GO:0042770
GeneOntologyCellularComponentcation channel complex

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80

6.23e-082358910GO:0034703
GeneOntologyCellularComponentmonoatomic ion channel complex

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80

4.74e-063788910GO:0034702
GeneOntologyCellularComponenttransmembrane transporter complex

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80

7.64e-055238910GO:1902495
GeneOntologyCellularComponenttransporter complex

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 PKD1 KCNS1 CNGB1 UNC80

1.16e-045508910GO:1990351
GeneOntologyCellularComponentcalcium channel complex

CACNA1C CACNA1E CACNA1F PKD1

2.67e-0473894GO:0034704
GeneOntologyCellularComponentmicrotubule minus-end

ASPM CAMSAP2

3.71e-047892GO:0036449
GeneOntologyCellularComponentperikaryon

CACNA1C CACNA1E CACNA1F DRP2 KCNB1 SLC4A10

3.83e-04223896GO:0043204
GeneOntologyCellularComponentchromosomal region

KAT5 TELO2 CENPH SPO11 MCM5 CHEK1 ATM XPO1

4.31e-04421898GO:0098687
GeneOntologyCellularComponentchromosome, telomeric region

TELO2 SPO11 MCM5 CHEK1 ATM

9.37e-04176895GO:0000781
GeneOntologyCellularComponentvoltage-gated calcium channel complex

CACNA1C CACNA1E CACNA1F

9.92e-0446893GO:0005891
GeneOntologyCellularComponentannulate lamellae

RANBP2 XPO1

1.58e-0314892GO:0005642
DomainChannel_four-helix_dom

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 KCNS1

9.56e-0957897IPR027359
Domain-

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 KCNS1

9.56e-09578971.20.120.350
DomainIon_trans_dom

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 KCNS1 CNGB1

7.04e-08114898IPR005821
DomainIon_trans

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 KCNS1 CNGB1

7.04e-08114898PF00520
DomainVDCC_a1su_IQ

CACNA1C CACNA1E CACNA1F

3.61e-067893IPR014873
DomainGPHH

CACNA1C CACNA1E CACNA1F

3.61e-067893PF16905
DomainGPHH_dom

CACNA1C CACNA1E CACNA1F

3.61e-067893IPR031649
DomainCa_chan_IQ

CACNA1C CACNA1E CACNA1F

3.61e-067893SM01062
DomainCa_chan_IQ

CACNA1C CACNA1E CACNA1F

3.61e-067893PF08763
DomainARM-type_fold

VAC14 TRPC4AP TELO2 INF2 IQCB1 ASPM INTS4 ATM XPO1 SDAD1

4.85e-063398910IPR016024
DomainVDCCAlpha1

CACNA1C CACNA1E CACNA1F

1.23e-0510893IPR002077
DomainCABLES1/2

CABLES2 CABLES1

2.25e-052892IPR012388
DomainCAC1F_C

CACNA1C CACNA1F

6.72e-053892IPR031688
DomainCAC1F_C

CACNA1C CACNA1F

6.72e-053892PF16885
DomainVDCC_L_a1su

CACNA1C CACNA1F

1.34e-044892IPR005446
DomainMOZ_SAS

KAT5 KAT6B

2.22e-045892PF01853
DomainHAT_MYST-type

KAT5 KAT6B

2.22e-045892IPR002717
DomainMYST_HAT

KAT5 KAT6B

2.22e-045892PS51726
DomainK_chnl_volt-dep_Kv

KCNB1 KCNV2 KCNS1

2.82e-0427893IPR003968
DomainARM-like

VAC14 TELO2 IQCB1 ASPM INTS4 XPO1 THAP11

3.06e-04270897IPR011989
DomainK_chnl_volt-dep_Kv9

KCNV2 KCNS1

4.64e-047892IPR003971
DomainCAMSAP_CH

ASPM CAMSAP2

4.64e-047892PF11971
DomainCAMSAP_CH

ASPM CAMSAP2

4.64e-047892IPR022613
DomainVG_K_chnl

KCNB1 KCNV2 KCNS1

5.15e-0433893IPR028325
DomainRan_BP1

RANBP1 RANBP2

1.44e-0312892PF00638
DomainRANBD1

RANBP1 RANBP2

1.44e-0312892PS50196
DomainRanBD

RANBP1 RANBP2

1.69e-0313892SM00160
DomainRan_bind_dom

RANBP1 RANBP2

1.69e-0313892IPR000156
DomainBTB_2

KCNB1 KCNV2 KCNS1

2.06e-0353893PF02214
DomainT1-type_BTB

KCNB1 KCNV2 KCNS1

2.06e-0353893IPR003131
DomainPLipase_C_Pinositol-sp_Y

PLCH1 PLCE1

2.26e-0315892IPR001711
DomainEF-hand_like

PLCH1 PLCE1

2.26e-0315892PF09279
DomainPIPLC_Y_DOMAIN

PLCH1 PLCE1

2.26e-0315892PS50008
DomainPI-PLC_fam

PLCH1 PLCE1

2.26e-0315892IPR001192
DomainPLC_EF-hand-like

PLCH1 PLCE1

2.26e-0315892IPR015359
DomainPI-PLC-Y

PLCH1 PLCE1

2.26e-0315892PF00387
DomainPLCYc

PLCH1 PLCE1

2.26e-0315892SM00149
DomainEF-hand-dom_pair

CACNA1C CACNA1F DRP2 PLCH1 STAT2 PLCE1

2.50e-03287896IPR011992
DomainHEAT

VAC14 INTS4 XPO1

2.67e-0358893IPR000357
DomainPI-PLC-X

PLCH1 PLCE1

3.27e-0318892PF00388
DomainPLCXc

PLCH1 PLCE1

3.27e-0318892SM00148
DomainPIPLC_X_DOMAIN

PLCH1 PLCE1

3.64e-0319892PS50007
DomainPLipase_C_PInositol-sp_X_dom

PLCH1 PLCE1

3.64e-0319892IPR000909
Domain-

VAC14 TELO2 ASPM INTS4 XPO1

4.19e-032228951.25.10.10
DomainKinase-like_dom

CDK17 MARK3 FER HIPK2 ACAD10 CHEK1 ATM CDK14

4.31e-03542898IPR011009
DomainHEAT_REPEAT

VAC14 INTS4 XPO1

4.55e-0370893PS50077
DomainIQ

MYO5B IQCB1 ASPM

4.73e-0371893PF00612
PathwayWP_GPR40_PATHWAY

PKD1 PLCH1 PLCE1

4.69e-0515683M39526
PathwayKEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY

CACNA1C CACNA1E CACNA1F

1.77e-0423683M47666
PathwayPID_P53_REGULATION_PATHWAY

KAT5 HIPK2 CHEK1 ATM

1.85e-0459684M261
PathwayBIOCARTA_RAN_PATHWAY

RANBP1 RANBP2

2.27e-045682M22082
PathwayKEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL

CACNA1C CACNA1E CACNA1F

2.29e-0425683M47948
PathwayREACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE

KAT5 CHEK1 ATM

2.58e-0426683MM15297
PathwayREACTOME_CELL_CYCLE_CHECKPOINTS

RANBP2 KAT5 CENPH MCM5 CHEK1 ATM XPO1

3.20e-04271687MM15388
PathwayREACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS

KAT5 ATM

3.40e-046682M27585
PathwayREACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS

KAT5 ATM

3.40e-046682MM15295
PathwayKEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY

CACNA1C CACNA1F

3.40e-046682M47762
PathwayREACTOME_CELL_CYCLE_CHECKPOINTS

RANBP2 KAT5 CENPH MCM5 CHEK1 ATM XPO1

4.91e-04291687M16647
PathwayBIOCARTA_PLK3_PATHWAY

CHEK1 ATM

6.30e-048682M22021
PathwayREACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS

RANBP1 RANBP2 XPO1

7.42e-0437683M27038
PathwayBIOCARTA_CDC25_PATHWAY

CHEK1 ATM

8.08e-049682M22031
PathwayKEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M

CHEK1 ATM

8.08e-049682M47586
PathwayREACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS

KCNB1 KCNV2 KCNS1

1.00e-0341683MM14546
PathwayREACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION

KAT5 HIPK2 CHEK1 ATM

1.01e-0392684MM15338
PathwayREACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION

KAT5 HIPK2 CHEK1 ATM

1.01e-0392684M27636
PathwayKEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M

CHEK1 ATM

1.01e-0310682M47572
PathwayREACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE

KAT5 CHEK1 ATM

1.15e-0343683M27588
PathwayREACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS

KCNB1 KCNV2 KCNS1

1.15e-0343683M1056
PathwayREACTOME_PEXOPHAGY

ATM EPAS1

1.23e-0311682M29846
PathwayPID_RANBP2_PATHWAY

RANBP2 XPO1

1.23e-0311682M140
PathwayKEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY

CACNA1C CACNA1E

1.23e-0311682M47958
Pubmed

Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development.

CACNA1C CACNA1E CACNA1F SCN11A KCNB1 KCNV2 KCNS1

8.56e-0813991716985003
Pubmed

Enhanced expression of L-type Cav1.3 calcium channels in murine embryonic hearts from Cav1.2-deficient mice.

CACNA1C CACNA1E CACNA1F

6.02e-07791312900400
Pubmed

p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress.

KAT5 CHEK1 ATM

9.61e-07891316705183
Pubmed

Large-scale mapping of human protein-protein interactions by mass spectrometry.

CFLAR CDK17 RANBP1 RANBP2 VAC14 GANAB HTR1E TELO2 MARK3 CENPH ASPM NIPSNAP2 MCM5 CDK14 SDAD1

1.17e-061284911517353931
Pubmed

International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.

CACNA1C CACNA1E CACNA1F

1.44e-06991316382099
Pubmed

The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.

RANBP1 RANBP2 XPO1

1.44e-06991310601307
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

JPH1 CDK17 RANBP1 RANBP2 TRPC4AP GANAB INF2 ASPM CHEK1 ATM XPO1 GDI2 AQR THAP11

1.81e-061155911420360068
Pubmed

Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway.

MARK3 CHEK1 ATM

2.82e-061191311551930
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

CABLES2 CACNA1E RANBP2 FAM193A SUPT6H FER MIOS ACAD10 GDI2

4.46e-0647591931040226
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

CACNA1C CACNA1E RANBP1 RANBP2 SCN11A PHACTR2 MYO5B ASPM NIPSNAP2 MCM5 ZBTB41 ATM ZFC3H1 PLCH1 CAMSAP2

4.85e-061442911535575683
Pubmed

Kv2.1 channels play opposing roles in regulating membrane potential, Ca2+ channel function, and myogenic tone in arterial smooth muscle.

CACNA1C KCNB1

6.77e-06291232015129
Pubmed

Localization of the calcium channel subunits Cav1.2 (alpha1C) and Cav2.3 (alpha1E) in the mouse organ of Corti.

CACNA1C CACNA1E

6.77e-06291212973680
Pubmed

KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.

KAT5 KAT6B

6.77e-06291224294372
Pubmed

A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM.

KAT5 ATM

6.77e-06291216141325
Pubmed

Compound heterozygous KCNV2 variants contribute to cone dystrophy with supernormal rod responses in a Chinese family.

KCNB1 KCNV2

6.77e-06291234535971
Pubmed

Mammalian meiosis involves DNA double-strand breaks with 3' overhangs.

SPO11 ATM

6.77e-06291212644952
Pubmed

Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability.

CACNA1C PKD1

6.77e-06291225888683
Pubmed

ATM promotes the obligate XY crossover and both crossover control and chromosome axis integrity on autosomes.

SPO11 ATM

6.77e-06291218497861
Pubmed

Molecular, Cellular and Functional Changes in the Retinas of Young Adult Mice Lacking the Voltage-Gated K+ Channel Subunits Kv8.2 and K2.1.

KCNB1 KCNV2

6.77e-06291234063002
Pubmed

Atm-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes.

CHEK1 ATM

6.77e-0629129382850
Pubmed

Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells.

CHEK1 ATM

6.77e-06291219401701
Pubmed

ATM and KAT5 safeguard replicating chromatin against formaldehyde damage.

KAT5 ATM

6.77e-06291226420831
Pubmed

Kidney Cyst Lining Epithelial Cells Are Resistant to Low-Dose Cisplatin-Induced DNA Damage in a Preclinical Model of Autosomal Dominant Polycystic Kidney Disease.

PKD1 ATM

6.77e-06291236293397
Pubmed

Zygotic G2/M cell cycle arrest induced by ATM/Chk1 activation and DNA repair in mouse embryos fertilized with hydrogen peroxide-treated epididymal mouse sperm.

CHEK1 ATM

6.77e-06291224040138
Pubmed

Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease.

PKD1 ATM

6.77e-06291233802342
Pubmed

De novo deletions and duplications at recombination hotspots in mouse germlines.

SPO11 ATM

6.77e-06291234793701
Pubmed

Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.

RANBP2 XPO1

6.77e-06291228600321
Pubmed

Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons.

CACNA1C CACNA1E CACNA1F

7.71e-061591320188150
Pubmed

Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression.

CACNA1C CACNA1E CACNA1F

7.71e-061591324453333
Pubmed

VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.

DDIAS TELO2 INF2 CENPH NFKB2 IQCB1 CHEK1

1.11e-0528891723383273
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

JPH1 CABLES2 PHACTR2 GANAB INF2 MARK3 PLCH1 CABLES1

1.53e-0542191836976175
Pubmed

Regulation of protein phosphatase 1I by Cdc25C-associated kinase 1 (C-TAK1) and PFTAIRE protein kinase.

MARK3 CDK14

2.03e-05391225028520
Pubmed

Electrically silent potassium channel subunits from human lens epithelium.

KCNB1 KCNS1

2.03e-05391210484328
Pubmed

The tumor suppressor, TAX1BP2, is a novel substrate of ATM kinase.

VAC14 ATM

2.03e-05391224240686
Pubmed

Key mediators of somatic ATR signaling localize to unpaired chromosomes in spermatocytes.

SPO11 ATM

2.03e-05391226209650
Pubmed

Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.

CHEK1 ATM

2.03e-05391220581453
Pubmed

ERK1/2 phosphorylates HIF-2α and regulates its activity by controlling its CRM1-dependent nuclear shuttling.

XPO1 EPAS1

2.03e-05391230962349
Pubmed

Novel inhibitors of nuclear transport cause cell cycle arrest and decrease cyst growth in ADPKD associated with decreased CDK4 levels.

PKD1 XPO1

2.03e-05391225234309
Pubmed

ik3-1/Cables is associated with Trap and Pctaire2.

CDK17 CABLES1

2.03e-05391211527406
Pubmed

Pectenotoxin-2 induces G2/M phase cell cycle arrest in human breast cancer cells via ATM and Chk1/2-mediated phosphorylation of cdc25C.

CHEK1 ATM

2.03e-05391220514472
Pubmed

Mutations in the nuclear export signal of human ran-binding protein RanBP1 block the Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1.

RANBP1 XPO1

2.03e-0539129111043
Pubmed

Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.

HIPK2 ATM

2.03e-05391211780126
Pubmed

An allosteric mechanism to displace nuclear export cargo from CRM1 and RanGTP by RanBP1.

RANBP1 XPO1

2.03e-05391220485264
Pubmed

Two distinct classes of Ran-binding sites on the nucleoporin Nup-358.

RANBP1 RANBP2

2.03e-05391210318915
Pubmed

A segregating human allele of SPO11 modeled in mice disrupts timing and amounts of meiotic recombination, causing oligospermia and a decreased ovarian reserve†.

SPO11 ATM

2.03e-05391231074776
Pubmed

A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export.

RANBP1 XPO1

2.03e-05391210330396
Pubmed

Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345.

CHEK1 XPO1

2.03e-05391212676962
Pubmed

Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells.

CHEK1 ATM

2.03e-05391217611684
Pubmed

The inhibition of HIF-2α on the ATM/Chk-2 pathway is involved in the promotion effect of arsenite on benzo(a)pyrene-induced cell transformation.

ATM EPAS1

2.03e-05391223333640
Pubmed

ATM pathway activation limits R-loop-associated genomic instability in Werner syndrome cells.

CHEK1 ATM

2.03e-05391230657978
Pubmed

ik3-2, a relative to ik3-1/Cables, is involved in both p53-mediated and p53-independent apoptotic pathways.

CABLES2 CABLES1

2.03e-05391214637168
Pubmed

The zebrafish grime mutant uncovers an evolutionarily conserved role for Tmem161b in the control of cardiac rhythm.

CACNA1C KCNV2

2.03e-05391233597309
Pubmed

The FATC domains of PIKK proteins are functionally equivalent and participate in the Tip60-dependent activation of DNA-PKcs and ATM.

KAT5 ATM

2.03e-05391216603769
Pubmed

The Role of the Voltage-Gated Potassium Channel Proteins Kv8.2 and Kv2.1 in Vision and Retinal Disease: Insights from the Study of Mouse Gene Knock-Out Mutations.

KCNB1 KCNV2

2.03e-05391230820446
Pubmed

ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.

CFLAR ATM

2.03e-05391217932249
Pubmed

Thymidylate kinase is critical for DNA repair via ATM-dependent Tip60 complex formation.

KAT5 ATM

2.03e-05391230199284
Pubmed

Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.

RANBP1 XPO1

2.03e-05391216041368
Pubmed

The E3 ubiquitin ligase APC/CCdh1 degrades MCPH1 after MCPH1-βTrCP2-Cdc25A-mediated mitotic entry to ensure neurogenesis.

KAT5 SUPT6H MCM5 THAP11

2.63e-056591429150431
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

MARK3 CENPH IQCB1 ASPM MIOS XPO1 ZFC3H1 SDAD1 AQR THAP11

3.02e-05759911035915203
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

JPH1 CDK17 GANAB FAM193A TELO2 INF2 MARK3 SUPT6H TRABD ASPM ATM ZFC3H1 PLCH1 AQR

3.14e-051487911433957083
Pubmed

Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals.

RANBP1 XPO1

4.05e-05491231021318
Pubmed

Epac2-dependent mobilization of intracellular Ca²+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in β-cells of phospholipase C-ε knockout mice.

PLCH1 PLCE1

4.05e-05491221041529
Pubmed

Mangrove dolabrane-type of diterpenes tagalsins suppresses tumor growth via ROS-mediated apoptosis and ATM/ATR-Chk1/Chk2-regulated cell cycle arrest.

CHEK1 ATM

4.05e-05491226061604
Pubmed

ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

CHEK1 ATM

4.05e-05491211390642
Pubmed

Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.

CHEK1 ATM

4.05e-05491221532626
Pubmed

NOTCH1 Inhibits Activation of ATM by Impairing the Formation of an ATM-FOXO3a-KAT5/Tip60 Complex.

KAT5 ATM

4.05e-05491227524627
Pubmed

RanBP1 stabilizes the interaction of Ran with p97 nuclear protein import.

RANBP1 RANBP2

4.05e-0549128909533
Pubmed

The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60.

KAT5 KAT6B

4.05e-05491217980166
Pubmed

SPO11 is required for sex-body formation, and Spo11 heterozygosity rescues the prophase arrest of Atm-/- spermatocytes.

SPO11 ATM

4.05e-05491215998665
Pubmed

Surveillance of different recombination defects in mouse spermatocytes yields distinct responses despite elimination at an identical developmental stage.

SPO11 ATM

4.05e-05491216055729
Pubmed

Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling.

CHEK1 ATM

4.05e-05491219903823
Pubmed

Beta-adrenergic-regulated phosphorylation of the skeletal muscle Ca(V)1.1 channel in the fight-or-flight response.

CACNA1C CACNA1F

4.05e-05491220937870
Pubmed

Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer.

CHEK1 ATM

4.05e-05491218381943
Pubmed

Isolated polycystic liver disease genes define effectors of polycystin-1 function.

GANAB PKD1

4.05e-05491228375157
Pubmed

Whole-genome association study of bipolar disorder.

CACNA1C MYO5B

4.05e-05491218317468
Pubmed

Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60.

KAT5 ATM

4.05e-05491219783983
Pubmed

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression.

CHEK1 ATM

4.05e-05491228808232
Pubmed

Structure of the Human TELO2-TTI1-TTI2 Complex.

TELO2 ATM

4.05e-05491234838521
Pubmed

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

CHEK1 ATM

4.05e-05491221034966
Pubmed

GTP hydrolysis links initiation and termination of nuclear import on the nucleoporin nup358.

RANBP1 RANBP2

4.05e-05491210473610
Pubmed

Facilitated nucleocytoplasmic shuttling of the Ran binding protein RanBP1.

RANBP1 XPO1

4.05e-05491210779340
Pubmed

Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.

CHEK1 ATM

4.05e-05491212676583
Pubmed

ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation.

HIPK2 ATM

4.05e-05491211875057
Pubmed

ATM controls meiotic double-strand-break formation.

SPO11 ATM

4.05e-05491222002603
Pubmed

XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer.

CHEK1 ATM

4.05e-05491229082250
Pubmed

Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer.

SUPT6H PKD1 CABLES1

5.41e-052891324462114
Pubmed

Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPalpha.

RANBP2 KAT5 MCM5

6.03e-052991318239623
Pubmed

Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.

CHEK1 ATM

6.74e-05591218480045
Pubmed

A giant nucleopore protein that binds Ran/TC4.

RANBP1 RANBP2

6.74e-0559127603572
Pubmed

Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.

HIPK2 ATM

6.74e-05591218536714
Pubmed

ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency.

CHEK1 ATM

6.74e-05591216675955
Pubmed

Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability.

KAT5 CHEK1

6.74e-05591229760279
Pubmed

Sam68 marks the transcriptionally active stages of spermatogenesis and modulates alternative splicing in male germ cells.

SPO11 ATM

6.74e-05591221355037
Pubmed

Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

CHEK1 ATM

6.74e-05591210859164
Pubmed

The many substrates and functions of ATM.

CHEK1 ATM

6.74e-05591211252893
Pubmed

Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice.

CACNA1C CACNA1E

6.74e-05591215451373
Pubmed

Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.

CHEK1 ATM

6.74e-05591212955071
Pubmed

ik3-2, a relative to ik3-1/cables, is associated with cdk3, cdk5, and c-abl.

CABLES2 CABLES1

6.74e-05591211955625
Pubmed

The Rad50 hook domain regulates DNA damage signaling and tumorigenesis.

SPO11 ATM

6.74e-05591224532689
Pubmed

Kv2.1 mediates spatial and functional coupling of L-type calcium channels and ryanodine receptors in mammalian neurons.

CACNA1C KCNB1

6.74e-05591231663850
InteractionMCPH1 interactions

KAT5 SUPT6H MCM5 CHEK1 ATM THAP11

5.66e-06101896int:MCPH1
InteractionEGLN3 interactions

CDK17 RANBP1 RANBP2 VAC14 GANAB FAM193A TELO2 TRABD IQCB1 ASPM MIOS NIPSNAP2 MCM5 XPO1 PLCH1 CDK14 CAMSAP2 EPAS1

1.21e-0512968918int:EGLN3
GeneFamilyCalcium voltage-gated channel subunits

CACNA1C CACNA1E CACNA1F

7.34e-0526573253
GeneFamilyPotassium voltage-gated channels

KCNB1 KCNV2 KCNS1

2.70e-0440573274
GeneFamilyZinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases

KAT5 KAT6B

1.14e-031657266
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

KAT5 KAT6B

1.29e-0317572486
GeneFamilyPhospholipases|C2 domain containing phospholipases

PLCH1 PLCE1

1.61e-0319572832
GeneFamilyCyclin dependent kinases

CDK17 CDK14

3.02e-0326572496
GeneFamilySH2 domain containing

SUPT6H FER STAT2

3.98e-03101573741
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CACNA1E TRABD CENPH ASPM CAMSAP2 RFPL3S S1PR4

5.78e-08169917c8691c4f707d46b2865fe46eabe24ea4d03c7b43
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F DRP2 PLCH1 PKHD1L1 DSCAML1 UNC80 PLCE1

1.03e-071849172cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F DRP2 PLCH1 PKHD1L1 DSCAML1 UNC80 PLCE1

1.03e-07184917ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNA1F DRP2 PLCH1 PKHD1L1 DSCAML1 UNC80 PLCE1

1.03e-071849172b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellChildren_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

CACNA1E KLHDC8A SLC4A10 DSCAML1 SLC16A12 UNC80

1.23e-06167916c87ebfa8c3284ad33579190e148c95bcaf670d17
ToppCellCOVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

CACNA1C HIPK2 PLEKHG2 DSCAML1 SLC16A12 PLCE1

2.15e-0618491621790cdfa3b4036ad413fd44b94e31563116f25f
ToppCellMid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CACNA1C KCNB1 PKD1 SLC4A10 CDK14 UNC80

3.10e-06196916676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCellSomatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CACNA1C KCNB1 PKD1 SLC4A10 CDK14 UNC80

3.29e-06198916c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

DDIAS RANBP1 CENPH ASPM MCM5 CHEK1

3.48e-0620091697e47eb69d1d4cab45256acca9589837eb7817e7
ToppCellNeuronal|World / cells hierarchy compared to all cells using T-Statistic

CACNA1C KCNB1 PKD1 SLC4A10 CDK14 UNC80

3.48e-0620091648d801219bc771d6c7e151dc88ca4c179988de85
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

DDX60L ATM SLFN5 XPO1 ZFC3H1 STAT2

3.48e-0620091612f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellE17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TCF21 MARK3 LRP4 ABCB11 SLC16A12

1.42e-05150915201d5b68e71c6c003285428be96c488e6d526edf
ToppCellfacs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANKRD22 ATCAY PLEKHG2 DSCAML1

1.53e-05739143ac392ac46ad577c7d2c2b5e6a0a96ceb613097b
ToppCellfacs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANKRD22 ATCAY PLEKHG2 DSCAML1

1.53e-05739141bd6ff9659efc43b0a596da50e325bde2f0ba8f7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

VAC14 TCP11L2 NFKB2 FER SLC4A10

2.00e-05161915c54010d88f1ecb6e0235bb66084876a4d5bf1ecd
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

JPH1 RANBP1 CENPH MCM5 CHEK1

2.06e-051629153f264263878af630921911c2b344ac56eb1e7099
ToppCellcontrol-dn_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CACNA1F PHACTR2 ASPM SLFN5 S1PR4

2.60e-05170915839f62860b4a52d06e6a8fce7632195c7310b89d
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CFLAR IL16 TCF21 LRP4 STAT2

3.24e-05178915c87945146b2734141f07b39d268e0d8086ee0364
ToppCell3'_v3-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue

ASPM MCM5 CHEK1 PKHD1L1 CNGB1

3.32e-051799157d3bd1f9e126a4a9e0a84720a6cc0b3d235e65ee
ToppCellPosterior_cortex-Hematopoietic-MICROGLIA|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

CACNA1F IL16 GDI2 SLC2A5 NCKAP1L

3.32e-051799155122fc794509492afde4af8b1b76d51e3070ef05
ToppCell10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue

RANBP1 CENPH ASPM MCM5 CHEK1

3.60e-0518291581557cdc88777f3bd4e1dd18a760b08fc29122ef
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue

DRP2 CENPH ASPM MCM5 CHEK1

3.69e-05183915a48a6313f2f144586951cece97ec31f6d72361df
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JPH1 MYO5B CENPH PKHD1L1 SLC16A12

3.69e-05183915919c9861073d12fd12aecd7469b1478b13838c43
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32

RANBP1 CENPH ASPM MCM5 CHEK1

3.69e-05183915f20b0d71f857ac35868fd80531050ad8b6091716
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DDIAS CENPH ATCAY ASPM MCM5

3.79e-051849151edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DDIAS CENPH ATCAY ASPM MCM5

3.79e-051849158578c50eaa8ce1cefc0228185c66c8e25f4bfc32
ToppCelldroplet-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHACTR2 SLFN5 CNGB1 EPAS1 CABLES1

3.89e-05185915512a195ebbae445afe3722a3943020080daf2f3c
ToppCellCOVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type

DDIAS IQCB1 ASPM CDK14 SLC2A5

3.99e-0518691566676d9395172de5707e204826a1c9f73b448cca
ToppCellRV-07._Pericyte|RV / Chamber and Cluster_Paper

HIPK2 DSCAML1 SLC16A12 EPAS1 PLCE1

3.99e-05186915c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCellRV-07._Pericyte|World / Chamber and Cluster_Paper

CACNA1C HIPK2 DSCAML1 SLC16A12 EPAS1

4.09e-05187915dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCelldroplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CENPH ASPM MCM5 CHEK1 PLCH1

4.20e-051889150ec2a1b0505501ba18f10a5fce68c306a6292419
ToppCellnormal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex

JPH1 CENPH ASPM MCM5 CHEK1

4.31e-051899151d382f8eb998c6a30e09fddc9a427afc8f5f7323
ToppCellMacrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

DDIAS INF2 DDX60L S1PR4 NCKAP1L

4.31e-05189915c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9
ToppCellnormal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex

JPH1 CENPH ASPM MCM5 CHEK1

4.31e-05189915b83fd81ecc5ef363be7435ee12cb7079e2434af7
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1C TCF21 ABCA6 CDK14 SLC16A12

4.31e-051899152a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCellnormal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

JPH1 CENPH ASPM MCM5 CHEK1

4.31e-051899153db4177d68cab4cd16842d2ebcaca28f69300e44
ToppCellCOVID-19-Lymphoid-Plasma,_B_cells|Lymphoid / Condition, Lineage and Cell class

HIPK2 CDK14 PKHD1L1 SLC2A5 CABLES1

4.53e-05191915bcdadf83cb9653f9cc2a281e7c1095fe8f79173c
ToppCellcontrol-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

RANBP1 CENPH ASPM MCM5 CHEK1

4.76e-05193915ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

DDIAS CENPH ASPM MCM5 CHEK1

4.87e-05194915590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

DDIAS RANBP1 CENPH MCM5 CHEK1

4.99e-05195915cec7df321f372d05c94f97d6bb18891a5cc3dec3
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

DDIAS RANBP1 CENPH MCM5 CHEK1

4.99e-05195915b65463a804fed2d9a3be9e528ca8b9c98469bc86
ToppCellmild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

RANBP1 CENPH ASPM MCM5 CHEK1

4.99e-051959159a8cc9097a349fd0a53ccf2723ee8bb1418d6aca
ToppCellILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

RANBP1 CENPH ASPM MCM5 CHEK1

5.12e-051969156a415a2574bd84bd825a2bd6c8e3632a433ff7cf
ToppCelllymphoid-T_cell-Regulatory_T_cell|World / Lineage, cell class and subclass

INF2 SLC4A10 SLFN5 PTGDR2 S1PR4

5.12e-0519691542a4d706382be33d552ece1d0598d073857a8d4e
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

DDIAS RANBP1 CENPH MCM5 CHEK1

5.12e-05196915df366d76ea55f49e349d622effa57c1535df8400
ToppCellsevere-T/NK_proliferative|severe / disease stage, cell group and cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.12e-0519691589f005216770dbb84378f5d1f20ca11b0ce40faa
ToppCellmild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

RANBP1 CENPH ASPM MCM5 CHEK1

5.12e-05196915b1d9866d5dfaefdb8bedaf01a750d97987acb3d1
ToppCell343B-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ANKRD22 ASPM MCM5 CHEK1 GDI2

5.24e-05197915b340d6f041231e5c69140895aaa1e8d28bafb998
ToppCellsevere-T/NK_proliferative|World / disease stage, cell group and cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.24e-051979156b7b068b103fd4f6ceda8e01f4dd39eefc3b3633
ToppCell10x5'-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue

RANBP1 CENPH ASPM MCM5 CHEK1

5.24e-051979151f7c3d193647b66cce6ea202a40758cd10b8bd12
ToppCell10x5'-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue

RANBP1 CENPH ASPM MCM5 CHEK1

5.24e-05197915acd678586aa0e4375bc8fbcdaa1a796c8dd23885
ToppCellmyeloid-CD34+_Monoblast|myeloid / Lineage and Cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.37e-05198915e26b98a8380e693110a97d8e5a353998f8d67c6d
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CENPH ASPM MCM5 CHEK1 SLC2A5

5.37e-05198915cfbe0bae21b6cd9cd15d3e659b618b44cfe3eaec
ToppCellsevere-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

RANBP1 CENPH ASPM MCM5 CHEK1

5.37e-051989154d8591eabb543ed789f963b507a07c560c76a7c9
ToppCell(0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

DDIAS CENPH ASPM MCM5 CHEK1

5.37e-05198915d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb
ToppCellprimary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CACNA1C KCNB1 SLC4A10 CDK14 UNC80

5.37e-051989156d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCellMS-cycling-|MS / Condition, Cell_class and T cell subcluster

DDIAS ASPM MCM5 CHEK1 PKHD1L1

5.37e-0519891519c5d6b65de490118574b1f86b45c58b3a51df7f
ToppCellmetastatic_Lymph_Node-T/NK_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass

RANBP1 CENPH ASPM MCM5 CHEK1

5.37e-05198915f9f083c76c51b6f014ecf80eaec957eff8d1ab75
ToppCellMS-cycling|MS / Condition, Cell_class and T cell subcluster

DDIAS ASPM MCM5 CHEK1 PKHD1L1

5.37e-051989150c22f2cc0e5ca91cabcd4aac2b9ef05af47e967f
ToppCellNon-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster

RANBP1 CENPH ASPM MCM5 CHEK1

5.37e-05198915672c6faeed54e1397e12c0aac1a5cbd19c684f06
ToppCellBAL-Severe|BAL / Compartment, Disease Groups and Clusters

CFLAR ANKRD22 DDX60L SLFN5 STAT2

5.37e-05198915f63cfcc57f46094ea0673bbc70ea443ebaca6176
ToppCellsevere-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ASPM CDK14 PKHD1L1 SLC2A5 CABLES1

5.50e-051999156ee4c2e6049860071169366b7e662d5c1a3cc54b
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-051999154394dcd1809f49e9bada8f5e115d5123356eae3e
ToppCellremission-T/NK_proliferative|remission / disease stage, cell group and cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-05199915303a5fc43a48b05b6f2060d99eef4adc36f8d4e3
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-05199915c0ea391bb347b99b94b5d7f02612ede938986745
ToppCellnormal_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-051999154142d5b1b20212508f95841fdac4efb7655616cb
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-0519991596af1f289552f38f2dfa181192eb3276f4c7d70b
ToppCellremission-T/NK_proliferative|World / disease stage, cell group and cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-05199915f305f3a454b7d2170429bad087480ccccca19acd
ToppCellCOVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-05199915893b78c661c529db07a5fcc3124d9b3d0f270fa5
ToppCellCOVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-05199915c608d953b852b67a4e36bd63d45f0deec3eefbd9
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-051999155b18e18ddbf4bd53aa0d574d23092cb96da7f400
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-051999156df65f4c2f9a125e0c7c4f597fefc05a97fc8831
ToppCellsevere-Lymphocytic-Prol._cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-05199915b24315952b6ac6c8d2d3a7bd949a5b5392624d4e
ToppCellPBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-05199915cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

RANBP1 CENPH ASPM MCM5 CHEK1

5.50e-05199915f9bf94ab6b5b134f5b98a65340843b147941ab58
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class

IL16 PHACTR2 MCM5 SLFN5 S1PR4

5.50e-05199915f307d4887b28cf60a591439e278fd668409cb104
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

RANBP1 CENPH KLHDC8A ASPM NIPSNAP2

5.50e-0519991589d7622c4ae146900d963ac68c6bf011e8674665
ToppCellControl-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class

CACNA1F IL16 PHACTR2 SLFN5 S1PR4

5.63e-0520091510882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5
ToppCellNS-moderate-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-052009157b7a5800798a3e7eba164fbc28312dd09c57a2c3
ToppCellmetastatic_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-052009159c2095dcf70f1288d55d0ff4a97efd4fd8d0c9ee
ToppCellILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-05200915d92d3bc63a56a604d7b1d49e62d4304e5e4017f2
ToppCellSevere-T/NK_proliferative|Severe / Disease group and Cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-052009154723613a9f56bff422fc98722128d57b6adf3c5d
ToppCellILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-052009156ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4
ToppCellNS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DDIAS CENPH ASPM MCM5 CHEK1

5.63e-052009157f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29
ToppCellNeuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic

PHACTR2 MYO5B KLHDC8A PLCH1 PLCE1

5.63e-05200915107854f4855fc99c9f7e737eb246f0d868e6c5fd
ToppCellSevere-T/NK_proliferative|World / Disease group and Cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-05200915128d82eb4d5760adf872212d8e8b5787a889969f
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-05200915cfec2f712b870797fab3b0770f16feaafd37e8d5
ToppCellCOVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease, condition lineage and cell class

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-0520091500538c4cbab5da00b3a366717d38a3ba5cfe3f65
ToppCellmoderate-Lymphoid-NKT-proliferating|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

RANBP1 CENPH ASPM MCM5 CHEK1

5.63e-052009158692e6664f0bb2be990f7563888380bb47414626
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type.

DDIAS CENPH ASPM MCM5 CHEK1

5.63e-052009158f9e76048ae6f45218a09a95a2c4b31e8a8937b2
ToppCellfrontal_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PLEKHG2 SLC16A12 EPAS1 PTGDR2

1.15e-04122914c16110934172f174f4aefe14b81abce8514b30f0
ToppCellfrontal_cortex-Non-neuronal-pericyte_cell-Peri|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PLEKHG2 SLC16A12 EPAS1 PTGDR2

1.15e-04122914006ac4f6807e688554d36557d29d5e5a0bc3c36f
ToppCellfrontal_cortex-Non-neuronal-pericyte_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PLEKHG2 SLC16A12 EPAS1 PTGDR2

1.15e-04122914f3d9a5893fdee3562880fb6fc132b88169a7d997
ToppCellThalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)|Thalamus / BrainAtlas - Mouse McCarroll V32

RTF2 FER CNGB1 S1PR4

2.05e-0414291458bfff3284ae21150e4619511bd58622c16c5dde
ToppCellThalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)--|Thalamus / BrainAtlas - Mouse McCarroll V32

RTF2 FER CNGB1 S1PR4

2.05e-041429145fd737c1fee9d97aee8955f1bf378ead3fce138d
ToppCellThalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Pi16_(Pi16)-|Thalamus / BrainAtlas - Mouse McCarroll V32

RTF2 FER CNGB1 S1PR4

2.05e-0414291416f9945e835c3506b12d904778560d065a50f059
ToppCellNS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ASPM MCM5 CNGB1 SLC2A5

2.17e-041449140fde5cd82df9b90aefde19275cff6c2ec3c9d5cb
ToppCellStriatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Lmo2_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32

ANKRD22 SPO11 PKHD1L1

2.40e-0459913dbb61f03be7d2c7fa7d32c743fcff2dc91ae0d75
ToppCellStriatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Lmo2_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32

ANKRD22 SPO11 PKHD1L1

2.40e-0459913e6cbbe1a4961066cae8f8c03a838f37e60a5391a
ToppCellLPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CACNA1F STX19 MYO5B DSCAML1

2.53e-041509149cb3332924bd67c966873343c14445e30d3f384f
DrugNaftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A

CFLAR VAC14 SUPT6H NFKB2 FER ACAD10 KAT6B EPAS1 S1PR4

8.36e-081969092974_DN
DrugNSC683246

CACNA1C CDK17 PKD1 HIPK2 ABCB11 CHEK1 XPO1 CDK14 EPAS1

3.76e-07234909CID000005097
DrugAC1L1KS5

CACNA1C CACNA1E CACNA1F KAT5 PKD1 PLCH1 PTGDR2 SLC2A5 PLCE1

7.03e-06334909CID000005631
DrugAC1L2AC7

CACNA1C CACNA1E CACNA1F NFKB2 PKD1

7.94e-0669905CID000068733
DrugCNS 1145

CACNA1C CACNA1E CACNA1F PKD1

8.56e-0633904CID000190902
DrugIHC-64

CACNA1C CACNA1E CACNA1F PKD1

8.56e-0633904CID000162753
DrugAlprenolol hydrochloride [13707-88-5]; Down 200; 14uM; HL60; HG-U133A

CFLAR RANBP2 HIPK2 KCNS1 ATM SLC2A5 NCKAP1L

1.37e-051989071571_DN
DrugBasic Violet 11:1

CFLAR ATM

1.55e-052902CID000062265
DrugU46619

CACNA1C CACNA1E CACNA1F SUPT6H PKD1 PLCH1 PTGDR2 PLCE1

1.74e-05285908CID000005618
Drugverapamil

CACNA1C CACNA1E CACNA1F KCNB1 ABCA6 MYO5B KCNV2 PKD1 ABCB11 KCNS1

2.39e-054909010CID000002520
DrugAC1NUZ8M

CFLAR CACNA1C NFKB2 PKD1 PTGDR2

3.24e-0592905CID000073211
Drug[(4E)-4-[(2,2-difluoroethylamino)methylene]-6-methyl-5-oxo-3-pyridyl]methyl dihydrogen phosphate

CACNA1E IL16 ABCB11

3.90e-0517903CID011840958
DrugIsradipine

CACNA1E CACNA1F ABCB11

4.67e-0518903ctd:D017275
DrugICRF-193

CHEK1 ATM XPO1 CDK14

6.21e-0554904CID000115150
Drugbenzyloxycarbonylleucyl-leucyl-leucine aldehyde

CFLAR KAT5 MYO5B PKD1 HIPK2 NIPSNAP2 MCM5 CHEK1 PLEKHG2 EPAS1

7.12e-055589010ctd:C072553
Drugpapaverine

CACNA1C CACNA1E CACNA1F PKD1 PLCH1 PLCE1

7.13e-05176906CID000004680
DrugCinildipine

CACNA1C CACNA1E CACNA1F PKD1

7.17e-0556904CID000002752
Drugpyrachlostrobin

DDIAS PHACTR2 MYO5B KLHDC8A NFKB2 ASPM LRP4 ACAD10 SLFN5 PLEKHG2 EPAS1 PLCE1

8.23e-058119012ctd:C513428
Drugnilvadipine

CACNA1C CACNA1E CACNA1F PKD1

9.40e-0560904CID000004494
DrugIAA-94

CACNA1C CACNA1E CACNA1F PKD1

1.00e-0461904CID000003667
DrugAC1NBU2S

CACNA1C CACNA1E CACNA1F NFKB2 PKD1

1.02e-04117905CID004473765
DrugEtidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A

CFLAR TRPC4AP HTR1E ACAD10 ATM AQR

1.03e-041889063325_DN
DrugEGTA-AM

CACNA1C CACNA1E RANBP2 XPO1

1.07e-0462904CID000121907
DrugNSC759576

CACNA1C CACNA1E CACNA1F NFKB2 PKD1 CNGB1

1.12e-04191906CID000003075
Druglercanidipine

CACNA1C CACNA1E CACNA1F PKD1

1.14e-0463904CID000065866
DrugCefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A

CFLAR NFKB2 KCNS1 ATM STAT2 PLCE1

1.25e-041959064148_UP
DrugSulpiride [15676-16-1]; Up 200; 11.8uM; HL60; HG-U133A

CFLAR GANAB SUPT6H TRABD KCNS1 CHEK1

1.29e-041969061967_UP
DrugPipemidic acid [51940-44-4]; Down 200; 13.2uM; HL60; HT_HG-U133A

CFLAR CDK17 KCNS1 AQR STAT2 SLC2A5

1.29e-041969063093_DN
DrugHarmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A

CFLAR KAT5 NFKB2 MIOS KCNS1 ATM

1.32e-041979062892_UP
Druggenistein; Up 200; 10uM; MCF7; HT_HG-U133A

CFLAR FER HIPK2 ACAD10 PLCH1 AQR

1.32e-041979066994_UP
DrugPhenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A

CFLAR TELO2 SUPT6H FER ATM KAT6B

1.32e-041979062868_DN
DrugFluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A

IL16 KCNB1 KCNS1 EPAS1 PTGDR2 STAT2

1.32e-041979066083_UP
Drugsodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A

VAC14 KAT5 KCNB1 SUPT6H MCM5 NCKAP1L

1.36e-04198906407_DN
Drugrosiglitazone maleate; Up 200; 10uM; HL60; HG-U133A

CFLAR VAC14 TELO2 TRABD HIPK2 ATM

1.36e-04198906369_UP
DrugNisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; HL60; HT_HG-U133A

INF2 TRABD HIPK2 CAMSAP2 EPAS1 S1PR4

1.36e-041989063117_DN
DrugSarin

CFLAR RANBP1 HTR1E KAT5 HIPK2 KAT6B GDI2

1.41e-04286907ctd:D012524
Druggallopamil

CACNA1C CACNA1E CACNA1F PKD1

1.45e-0467904CID000001234
DiseaseAutosomal dominant polycystic kidney disease

GANAB PKD1

2.75e-053902cv:C0085413
DiseaseCholestasis, progressive familial intrahepatic 1

MYO5B ABCB11

5.50e-054902C4551898
DiseaseTimothy syndrome (implicated_via_orthology)

CACNA1C CACNA1F

5.50e-054902DOID:0060173 (implicated_via_orthology)
Diseasetotal blood protein measurement

CFLAR CABLES2 TRPC4AP ABCA6 CENPH PKD1 XPO1 PLCE1

7.04e-05449908EFO_0004536
DiseaseDuchenne muscular dystrophy (implicated_via_orthology)

CACNA1C CACNA1F DRP2

1.82e-0436903DOID:11723 (implicated_via_orthology)
DiseasePolycystic kidney disease, type 2

GANAB PKD1

1.91e-047902C2751306
DiseasePolycystic Kidney, Type 1 Autosomal Dominant Disease

GANAB PKD1

2.55e-048902C0887850
DiseaseCharcot-Marie-Tooth disease

JPH1 DRP2 INF2

2.89e-0442903cv:C0007959
DiseasePolycystic Kidney, Autosomal Dominant

GANAB PKD1

3.27e-049902C0085413
Diseasegastric adenocarcinoma (is_implicated_in)

XPO1 PLCE1

4.97e-0411902DOID:3717 (is_implicated_in)
Diseasepulse pressure measurement

VAC14 FAM193A MARK3 SUPT6H PKD1 FER ABCB11 ZBTB41 ACAD10 CDK14 CCNYL2 PLCE1

1.06e-0313929012EFO_0005763
DiseaseMyopia

SCN11A TCP11L2 MYO5B DDX60L DSCAML1 SLC2A5

1.18e-03385906HP_0000545
Diseasecoagulation factor measurement

ASPM ZBTB41

1.69e-0320902EFO_0004634
DiseaseGranulomatous Slack Skin

NFKB2 ATM

2.04e-0322902C0376407
Diseaseamblyopia

CACNA1E CNGB1

2.04e-0322902MONDO_0001020
Diseasehippocampal volume

SLC4A10 ABCB11 MCM5 DSCAML1 SDAD1

2.19e-03297905EFO_0005035
DiseaseRenal glomerular disease

INF2 PLCE1

2.23e-0323902C0268731
DiseaseLymphoma, T-Cell, Cutaneous

NFKB2 ATM

2.23e-0323902C0079773
DiseaseGlomerulopathy Assessment

INF2 PLCE1

2.23e-0323902C4521256
DiseaseImmunologic Deficiency Syndromes

CACNA1C ATM

2.23e-0323902C0021051

Protein segments in the cluster

PeptideGeneStartEntry
LDKASIMRLAISFLR

EPAS1

51

Q99814
KERLLRISIRHMVKS

CACNA1E

461

Q15878
QRLVKRMTRFFTKLD

CHEK1

371

O14757
QVFAMARLRFLKLKR

ABCA6

836

Q8N139
ARKRTAKRAALMILT

HTR1E

131

P28566
RALALMKARVKSRLA

ACAD10

931

Q6JQN1
LLTKRLRKFGFRAML

ABCB11

826

O95342
KSRFAIRKIMLLEFS

AQR

56

O60306
RRLKFSQIELMLRKA

ANKRD22

176

Q5VYY1
MKKLRRTLSESFSRI

CDK14

16

O94921
MKTLRARFKKTELRL

ANKRD24

1

Q8TF21
RVRRFDLLKRILKMD

CFLAR

61

O15519
YAEMREKLRLRLTKR

FAM193A

811

P78312
LMMRRRFLSLKKTAI

ASPM

2276

Q8IZT6
ILRHKTSGKIRLLMR

RANBP2

1221

P49792
IRLLMRRDKTLKICA

RANBP1

86

P43487
LEFRKARSDMLLSRK

NIPSNAP2

151

O75323
LDKKLMSDLRRKRTA

INTS4

321

Q96HW7
KRTTFLKKHRMLGRL

KAT6B

621

Q8WYB5
RLFRVMRLVKLLSKG

CACNA1F

1296

O60840
EVRNALMKLLRRKIS

OR8D4

296

Q8NGM9
LMGLFEKRRFRKFLV

GDI2

131

P50395
DRREFIDLLKKMLTI

HIPK2

496

Q9H2X6
HLAAKLANRRMKRIL

NMS

96

Q5H8A3
MLSRIEKQLKRRFAI

MCM5

671

P33992
MIDRRLRKNLKSLII

ATCAY

256

Q86WG3
RAMLKRLLRIDSKCL

KAT5

486

Q92993
LFRRGSLLGSMKLRK

JPH1

211

Q9HDC5
VLKHSLLSFKRRRAM

DDX60L

1376

Q5H9U9
LLSFKRRRAMETLKL

DDX60L

1381

Q5H9U9
KLIFRFVRTLFKAMR

CCNYL2

191

Q5T2Q4
MNRRRKFLLASVLAL

DDIAS

1

Q8IXT1
RKSAKFRSISRSLML

IL16

11

Q14005
KLKTRNRESISLLMR

NCKAP1L

1076

P55160
LMRIFRVLKLARHST

KCNS1

346

Q96KK3
MKKFKRRLSLTLRGS

CDK17

1

Q00537
EAKMELKRRLSRKLS

PHACTR2

546

O75167
MLRKLRRSLRTVLES

PTGDR2

311

Q9Y5Y4
STMKAFRDLFLRALK

INF2

911

Q27J81
LRNKDMKGALRRLLA

OR2B11

296

Q5JQS5
VSFRAADIRRKLLML

ATM

916

Q13315
IMRILRILKLARHST

KCNB1

301

Q14721
FRLFRVMRLVKLLSR

CACNA1C

1376

Q13936
LTLSKIRSLKREMRK

CABLES1

511

Q8TDN4
FEIKKLALDRMRLST

CENPH

96

Q9H3R5
ELRLLETVKKFMALR

FER

21

P16591
LKRLRDAKSLAEMLI

DSCAML1

1621

Q8TD84
KLTRRNMSFRFIKRL

MARK3

611

P27448
RSFRSKRSKMLLEIN

IQCB1

326

Q15051
LKMERSFFLKKRRAD

KLHDC8A

256

Q8IYD2
AARRKARRLLKTVLM

S1PR4

241

O95977
KLTLSKIRSLKREMR

CABLES2

356

Q9BTV7
AMKRAALLEKRLRRE

CAMSAP2

1176

Q08AD1
AMKLRRVQKALRLDL

DRP2

406

Q13474
ARKVKRLHGMLRSLL

PKD1

3661

P98161
VLKTRMEERRLRAKL

RTF2

181

Q9BY42
MINLLKRFSSERKLL

VAC14

531

Q08AM6
ERRLLKKTMSGTFLL

STAT2

586

P52630
TSLVILMLARRKERL

TRPC4AP

691

Q8TEL6
SLIDKRIKLYMRRLL

TCP11L2

436

Q8N4U5
LLGFARLIKRMRKTQ

SLC16A12

456

Q6ZSM3
GLLELTRAVRKMRKF

PLCE1

1001

Q9P212
TMLERLASKRRKLVA

GANAB

451

Q14697
GFISVLKLFRMRSLR

SLC2A5

261

P22732
LMRIFRILKLARHST

KCNV2

381

Q8TDN2
RLMKMARLLARFLRE

TELO2

116

Q9Y4R8
LRMTFCKALILLRNK

SDAD1

96

Q9NVU7
SLATMIDRIKRHLKL

NIF3L1

261

Q9GZT8
KEDLLRRLKLVKMYR

SFR1

166

Q86XK3
ESQKLLRKKARRMLR

CNGB1

1071

Q14028
LRIRKENLTRLFEKM

SUPT6H

406

Q7KZ85
RSMRTVKRETLKLIS

XPO1

746

O14980
ALILILKRLDRMFNK

UNC80

2581

Q8N2C7
LEKDIATKMRLRALS

MIOS

386

Q9NXC5
LTKRDQMKLDSILRR

SPO11

331

Q9Y5K1
DAFNLLLEMKLKRRR

TRABD

41

Q9H4I3
KSLVASMRRFSLLKR

STX19

76

Q8N4C7
LRTLLRSSEMRRKLL

RFPL3S

21

P0C7P2
LKMLERSFSARRSKR

ZBTB41

241

Q5SVQ8
LVFVRKLMDLLFTKR

SLC4A10

1016

Q6U841
RMRVLSKAFSRLKTT

TCF21

91

O43680
KSLRRKRSMGFIIEI

PKHD1L1

3981

Q86WI1
RRKTMKLCRELSDLV

PLCH1

591

Q4KWH8
LRRLMKEKQRLSTSR

ZNF830

21

Q96NB3
MELKSFRTLRALRPL

SCN11A

1141

Q9UI33
LLFLFSRMLLVAKRR

PLEKHG2

336

Q9H7P9
LREKDRLLAMAVIRK

THAP11

296

Q96EK4
MLLREELLKSLANKR

ZFC3H1

626

O60293
RLLTAMRKRKLSQLH

SLFN5

806

Q08AF3
DKFLLFARRMDIRRI

LRP4

741

O75096
MLKARRELKALRIEA

MYO5B

896

Q9ULV0
LKKVMDLSIVRLRFS

NFKB2

181

Q00653